Colorectal cancer surveillance for patients with inflammatory bowel disease

Gastrointestinal Endoscopy Clinics of North America

Volumn 12, Issue 1, 2002, Pages 135-143

  Lashner, Bret A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; ENTERITIS; HUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0036144953     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5157(03)00063-1     Document Type: Review

References (34)

1. Risk factors for colorectal cancer in inflammatory bowel disease
2. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy
3. Mutations in p53 gene: An early marker of neoplastic progression in ulcerative colitis
4. Birth-cohort phenomenon in the time trends of mortality from ulcerative colitis
5. A decision analysis of surveillance for colorectal cancer in ulcerative colitis
6. Colorectal cancer prevention in ulcerative colitis: A case-control study
7. How gastroenterologists screen for colonic cancer in ulcerative colitis: An analysis of performance
8. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
9. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis
10. Increased p53 mutation load in non-cancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
11. Ulcerative colitis and colorectal cancer: A follow-up study in Fukuoka, Japan
12. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study
13. Increased risk of cancer in ulcerative colitis: A population-based cohort study
14. Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: Relation to dysplasia and DNA aneuploidy
15. Colorectal cancer risk and mortality in patients with ulcerative colitis
16. Inflammatoary bowel diseases with onset in childhood: Clinical features, morbidity, and mortality in a regional cohort
17. Recommendations for colorectal cancer surveillance in ulcerative colitis: A review of research from a single university-based surveillance program
18. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis
19. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis
20. Hazard rates for dysplasia and cancer in ulcerative colitis: Results from a surveillance program
21. Dyspalsia and cancer complicating strictures in ulcerative colitis
22. Eighteen-year surveillance of dysplasia-associated lesion in ulcerative colitis
23. Microsatellite instability and k-ras mutations in patients with ulcerative colitis
24. Adenomas and adenoma-like DALMs in chronic ulcerative colitis: A clinical, pathological, and molecular review
25. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence study
26. Chronic inflammatory bowel disease and cancer
27. Prophylactic colectomy for surveillance for chronic ulcerative colitis? A decision analysis
28. Performing a cost-effectiveness analysis: Surveillance of patients with ulcerative colitis
29. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis
30. Colonoscopic polypectomy in chronic colitis: Conservative management after endoscopic resection of dysplastic polyps
31. The risk of cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis
32. Ulcerative colitis in Greece: Clinicoepidemiological data, course, and prognostic factors in 413 consecutive patients
33. Ursodiol is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis
34. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen County diagnosed between 1973 and 1993